Skip to main content
Premium Trial:

Request an Annual Quote

Population Diagnostics, Empire Genomics Sign Co-Marketing Pact

NEW YORK (GenomeWeb News) - Population Diagnostics and Empire Genomics have signed a co-marketing agreement with the goal of developing molecular diagnostic tests, Population Diagnostics said today.
 
Under the terms of the “multifaceted” deal, EG of Buffalo, NY, will have access to PDI’s core technology platform for discovering copy number polymorphisms. EG will use PDI’s technology to support its internal and collaborative projects, as well as in service and supply relationships with third parties.
 
Melville, NY-based PDI, meanwhile, will use data from EG's array-based comparative genomics platform to build its own technology platform as well as its DNA biomarker discovery program.
 
The companies have also agreed to co-market and co-promote each other’s products and services.
 
PDI has built a working prototype of its platform, which the company claims has helped identify medically relevant biomarkers for autism.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.